Drug Patents owned by Nexus Pharms

1. List of Emerphed drug patents

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US11090278 NEXUS PHARMS Compositions comprising ephedrine or an ephedrine salt and methods of making and using same
May, 2040

(17 years from now)

US11241400 NEXUS PHARMS Compositions comprising ephedrine or an ephedrine salt and methods of making and using same
May, 2040

(17 years from now)

US11464752 NEXUS PHARMS Compositions comprising ephedrine or an ephedrine salt and methods of making and using same
May, 2040

(17 years from now)

US11478436 NEXUS PHARMS Compositions comprising ephedrine or an ephedrine salt and methods of making and using same
May, 2040

(17 years from now)

Drugs and Companies using EPHEDRINE SULFATE ingredient

Market Authorisation Date: 17 April, 2020

Treatment: Use of ephedrine sulfate for treating hypotension

Dosage: SOLUTION;INTRAVENOUS

How can I launch a generic of EMERPHED before it's patent expiration?
More Information on Dosage

availability in other generic markets.

Click on the highlighted region to filter.

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic